Post-approval studies (Phase 4)Study completedNCT04828993
What this trial is testing
The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
Who this might be right for
Transthyretin Amyloid Polyneuropathy (ATTR-PN)
Pfizer 15